DiwaliPicks2022 131022
DiwaliPicks2022 131022
DiwaliPicks2022 131022
Picks
2022
Sharekhan Diwali Picks - Consistent track record 0
Return (%)
Year Diwali Picks vs. Diwali Picks vs.
Diwali Picks Nifty CNX Midcap
Nifty CNX Midcap
2015 18 8.2 20.1
2017 4 3 -11
2018 8 10 -5.7
- Outperformance
- Underperformance
Sharekhan Diwali Picks 2022 (Samvat 2079) 0
Samvat 2078 has not been kind to investors and it seems like a roller-coaster ride. So, it’s no surprise that it has been one of the
toughest and most volatile on record. There are many factors that have attributed to the volatility, such as a higher global inflationary
environment, geopolitical tensions, liquidity tightening by central banks and the consequent slowing down in all major economies
globally.
In that context, our Diwali Picks 2021 basket, which was a mix of both large-caps and mid-caps, once again convincingly outperformed
the CNX Nifty index and CNX Midcap index with a 3.6% return versus a -6.5% return in the Nifty and -2.3% return in the midcap index.
Over the past seven years, our Diwali Picks have outperformed the Nifty for six out of the seven years, which is quite a feat.
Stepping into Samvat 2079, there is certainly the potential for more volatility in the near term given global uncertainties. Nevertheless,
Indian equities offer an attractive opportunity for investors on the back of growing conviction on a multi-year economic upcycle in India.
Corporate earnings are also likely to sustain the healthy momentum seen in the past eight consecutive quarters. Despite the potential
global slowdown, Nifty earnings are estimated to clock a decent 15% CAGR over FY22-FY24E, while an over 20% earnings growth is
expected in BSE 200 over the same period.
This year, we have handpicked a balanced portfolio of 15 high-quality stocks largely based on the theme of leveraging on domestic
upcycle and consumption play.
We remain constructive on equity as an asset class and more so on the India growth story. We advise investors use the market volatility
to construct a quality portfolio for long-term wealth creation.
Successful investing is all about time, discipline and patience – Warren Buffet
Wish you a Very Happy Diwali and a Prosperous New Year!
APL Apollo Bajaj Bank of
Coforge
Tubes Finance Diwali 2022 Baroda
Samvat 2079
• Lower slippages are expected to sustain over the medium term because of improvement in corporate credit cycle. Moreover, + = -
trailing loan growth in riskier segments was muted due to the pandemic.
RS
• Thus, NPA formation should moderate further. NNPA at 1.58%, a multi-year low.
RQ
• A combination of the above factors, along with improving loan growth and margin trajectory, should bode well for good RV
compounding in earnings going ahead.
• Key risks: Economic slowdown due to which slower loan growth and higher-than-anticipated credit cost, especially from Stock data
corporate and SME book, could affect earnings.
Market Cap (Rs. cr) 68,753
• HAL would hold the key in structural transformation of India’s defence sector that eyes a production target of $25 billion by 2025 + = -
through indigenization and higher exports under ‘Make in India’. RS
• HAL’s execution would ramp up, once large orders like LCA (Mk1A) kick in. Similarly, better operational efficiencies would drive RQ
OPM. Further, HAL is focused on growing exports to diversify its revenue base. RV
• HAL has strong government support, proven execution capabilities, capacity expansion, improving working capital cycle and healthy
cash balance of ~Rs. 14,000 crore. It trades at ~17x FY24E EPS, lower than listed peers. Stock data
Key risks: Fluctuations in raw material prices and delay in availability of key components could impact execution. Opening up of Market Cap (Rs. cr) 78,916
defence sector to private players may intensify competition going forward.
52-wk High-Low (Rs.) 2,638/1,181
• We are bullish on L&T given robust order book of Rs. 3.6 lakh crore (2.2x TTM revenue) and a promising long-term outlook. Market Cap (Rs. cr) 2,68,505
Key risks: Slowdown in the domestic macro-economic environment and geopolitical conflicts can affect order prospects. 52-wk High-Low (Rs.) 2,079/1,456
Key risks: The company has significant revenue exposure from Europe and thus is at the risk of regional economic situations. 52-wk High-Low (Rs.) 326/164
Neutral Stagnancy in the industry growth due to macro factors and lower incremental investments by Government/private companies
Unable to recover from low in the stable economic environment, adverse government policies affecting the business fundamentals and global challenges (currency
Negative
headwinds and unfavorable policies implemented by global industrial institutions) and any significant increase in commodity prices affecting profitability.
Right Quality
Sector leader, Strong management bandwidth, Strong financial track-record, Healthy Balance sheet/cash flows, differentiated product/service portfolio and Good
Positive
corporate governance.
Macro slowdown affecting near term growth profile, Untoward events such as natural calamities resulting in near term uncertainty, Company specific events such
Neutral
as factory shutdown, lack of positive triggers/events in near term, raw material price movement turning unfavourable
Weakening growth trend led by led by external/internal factors, reshuffling of key management personal, questionable corporate governance, high commodity
Negative
prices/weak realisation environment resulting in margin pressure and deteriorating balance sheet
Right Valuation
Strong earnings growth expectation and improving return ratios but valuations are trading at discount to industry leaders/historical average multiples, Expansion in
Positive
valuation multiple due to expected outperformance amongst its peers and Industry up-cycle with conducive business environment.
Neutral Trading at par to historical valuations and having limited scope of expansion in valuation multiples.
Trading at premium valuations but earnings outlook are weak; Emergence of roadblocks such as corporate governance issue, adverse government policies and bleak
Negative
global macro environment etc warranting for lower than historical valuation multiples.
Disclaimer 0
This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This Document may contain confidential and/or privileged material and is not for any type
of circulation and any review, retransmission, or any other use is strictly prohibited. This Document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the purchase or sale of
any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report at the same time. SHAREKHAN will not treat
recipients as customers by virtue of their receiving this report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be
relied upon as such. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no
obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not
intended to be and must not alone be taken as the basis for an investment decision. Recipients of this report should also be aware that past performance is not necessarily a guide to future performance and value of investments can go
down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the
securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed
may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusions from the information
presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use
would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all
jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
The analyst certifies that the analyst has not dealt or traded directly or indirectly in securities of the company and that all of the views expressed in this document accurately reflect his or her personal views about the subject company or
companies and its or their securities and do not necessarily reflect those of SHAREKHAN. The analyst and SHAREKHAN further certifies that neither he or his relatives or Sharekhan associates has any direct or indirect financial interest nor
have actual or beneficial ownership of 1% or more in the securities of the company at the end of the month immediately preceding the date of publication of the research report nor have any material conflict of interest nor has served as
officer, director or employee or engaged in market making activity of the company. Further, the analyst has also not been a part of the team which has managed or co-managed the public offerings of the company and no part of the
analyst’s compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document. Sharekhan Limited or its associates or analysts have not received any compensation for investment
banking, merchant banking, brokerage services or any compensation or other benefits from the subject company or from third party in the past twelve months in connection with the research report.
Either, SHAREKHAN or its affiliates or its directors or employees / representatives / clients or their relatives may have position(s), make market, act as principal or engage in transactions of purchase or sell of securities, from time to time
or may be materially interested in any of the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform
investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the
information have any liability for any damages of any kind.
Compliance Officer: Ms. Binkle Oza; Tel: 022-61150000; email id: [email protected];
For any queries or grievances kindly email [email protected] or contact: [email protected]
Registered Office: Sharekhan Limited, The Ruby, 18th Floor, 29 Senapati Bapat Marg, Dadar (West), Mumbai – 400 028, Maharashtra, INDIA, Tel: 022 – 67502000 / Fax – 022-24327343. Sharekhan Ltd.: SEBI Regn. Nos.: BSE / NSE / MSEI
(CASH / F&O / CD) / MCX - Commodity: INZ000171337; DP: NSDL/CDSL-IN-DP-365-2018; PMS: INP000005786; Mutual Fund: ARN 20669; Research Analyst: INH000006183
Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and the T&C on www.sharekhan.com; Investment in securities market are subject to market risks, read all the related documents carefully
before investing.